[go: up one dir, main page]

WO2001048455A2 - High viscosity sheath reagent for flow cytometry - Google Patents

High viscosity sheath reagent for flow cytometry Download PDF

Info

Publication number
WO2001048455A2
WO2001048455A2 PCT/US2000/035543 US0035543W WO0148455A2 WO 2001048455 A2 WO2001048455 A2 WO 2001048455A2 US 0035543 W US0035543 W US 0035543W WO 0148455 A2 WO0148455 A2 WO 0148455A2
Authority
WO
WIPO (PCT)
Prior art keywords
fluid
flow
viscosity
sheath
increasing agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/035543
Other languages
French (fr)
Other versions
WO2001048455A3 (en
Inventor
Richard Channing Moore
Anthony Ferrante
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Union Biometrica Inc
Original Assignee
Union Biometrica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Biometrica Inc filed Critical Union Biometrica Inc
Priority to AU26063/01A priority Critical patent/AU2606301A/en
Priority to JP2001548919A priority patent/JP2004500562A/en
Priority to CA002396015A priority patent/CA2396015A1/en
Priority to EP00989570A priority patent/EP1242804A2/en
Priority to US10/203,841 priority patent/US20040070757A1/en
Publication of WO2001048455A2 publication Critical patent/WO2001048455A2/en
Publication of WO2001048455A3 publication Critical patent/WO2001048455A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • G01N15/1404Handling flow, e.g. hydrodynamic focusing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/01Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • G01N15/1404Handling flow, e.g. hydrodynamic focusing
    • G01N15/1409Handling samples, e.g. injecting samples
    • G01N2015/1411Features of sheath fluids

Definitions

  • This invention pertains to a technology for counting and analysis of particles, generally called flow cytometry. Specifically, the invention deals with improvements which allow flow cytometry devices to: 1) handle large particles, including small elongate multicellular organisms, which are considerably larger than the particles on which flow cytometry machines are usually used, and/or 2) operate at significantly increased speeds.
  • Flow cytometry instruments optically analyze particles suspended in a fluid stream as the particles pass through a focussed light beam.
  • the instruments use hydrodynamic focusing to center particles in the fluid stream.
  • the fluid flow must be fully laminar, with no oscillations or turbulence. Needless to say, any imperfections in the hydrodynamic focusing degrade the performance of the instrument. Imperfect hydrodynamic focusing results in flow instabilities, and optical measurements are predicated upon the analyzed particle passing at a constant velocity through the center of the optical beam. In the face of instabilities and imperfect focussing these assumptions are not met and the resulting optical data are erroneous.
  • a sheath stream and sample fluid stream (containing suspended particles to be analyzed) are introduced into the flowcell in a pre-analysis section (chamber) of the flowcell.
  • the sheath stream is injected into the flowcell and allowed to flow for a sufficient distance to form a fully developed laminar flow profile.
  • the sample stream is injected into the center of this flow profile.
  • the sample fluid is thus kept centered in the flow channel of the flowcell by the laminar sheath flow that includes a velocity differential between the sheath and the sample streams.
  • the centered sample particles are analyzed as they pass through an "interrogation" station where a beam such as a laser beam traverses the flowcell and strikes the suspended particles one by one. Light emitted or scattered by the particles is received by one or more optical detectors that output optical data in response to the incident light.
  • the fluid stream is aimed into the well of a microtiter plate or other suitable receptacle.
  • the entire fluid stream would be deposited in the well were it not for the "fluid switch".
  • the fluid switch consists of a separate stream of focussed fluid which strikes the stream in air just below the flow cell.
  • the separate stream diverts the sample stream in air so that it goes to waste and does not enter the microtiter well. Because this intersection occurs below the flowcell, any shock waves or instabilities caused by the intersection are not transmitted upstream into the analysis region where they would spoil the analysis.
  • the "fluid switch" diverting fluid stream (control stream) is controlled by a high-speed fluidic valve.
  • the high-speed valve is closed at the correct instant to cause a section of stream in air containing the organism to pass unimpeded into the microtiter well. Then, the high-speed valve is reopened once again to divert the sample stream in air and prevent additional fluid or organisms from entering the microtiter well.
  • the microtiter tray is moved mechanically to bring another well into position to receive the stream in air, and the entire process is repeated to deposit a single desired organism in the well. In this way each of the wells of the microtiter tray receive a single selected organism.
  • FIG. 1 represents a simplified block diagram of such an instrument.
  • a source of suspended multicellular sample organisms 20 flow into the flowcell 24 which is represented by a dotted line. Sheath fluid from a container 22 enters the flowcell 24 and laminar flow develops as discussed below.
  • a laser beam (not shown) traverses the flow cell 24 and illuminates the organisms. Emitted and scattered light are received by optical detectors 28.
  • the signals are analyzed by a computer 30.
  • the computer output controls a fluidic valve 34 which switches fluid (i.e., compressed gas) from a source 36.
  • a control stream 38 emerging from the valve 34 is aimed onto a sample stream in air 40 that emerges from the lower end of the flowcell 26 forming a deflected stream 42 which goes to waste.
  • the deflected stream may be a mist of droplets.
  • Becton Dickinson and Company manufacture instruments, including the FACStar Plus and the FACScaliber, which are available with special flowcells with larger than normal flow channels. These instruments are intended for use with samples suspended in water, buffer or biological saline.
  • the present inventors have found significant advantages to the use in flow-cytometry instruments of a sheath fluid with a viscosity significantly higher than that of water or biological saline. There are two primary situations where a viscous sheath is of especial advantage:
  • the present inventors have found that increasing the viscosity of the sheath fluid dramatically decreases the flow length required to stabilize fully the flow.
  • This invention is critical for systems which require that the stream exit into air as a solid stream and not as droplets. If the flow rate is too slow, the stream will form droplets and drip out of the exit nozzle.
  • the high-viscosity sheath allows these systems to be run at a flow rate sufficiently high that the fluid exits the nozzle as a solid stream rather than as a series of drops.
  • An additional advantage of the high-viscosity sheath fluid is that large particles often settle out of the sample being analyzed before it reaches the flowcell. Increased viscosity of the sample fluid slows the rate at which the particles settle, making mixing of the samples easier and preventing settling in the sample lines.
  • sheath and sample fluid must have the same refractive index or the sample fluid will scatter light even when no particle is present. This means that modification of sheath viscosity will normally require a similar modification of the sample fluid.
  • the preferred embodiment of this invention consists of a short pre- analysis chamber, in which the sheath is delivered aligned with the axis of the flowcell (for example, through two opposed ports), an analysis chamber with a wide (1 mm) flow channel, and a nozzle through which the flow stream is discharged to air at the downstream end of the analysis section.
  • a solid stream of fluid is diverted by a switchable fluid stream (e.g. gas), which is turned off to dispense a particle.
  • a switchable fluid stream e.g. gas
  • the preferred agent is polyvinyl pyrollidone (PVP). This material can be effectively used over a considerable range of solution concentrations and molecular weight compositions.
  • a 5% by weight solution of a polymer with a 40,000 average molecular weight is effective.
  • Increasing the molecular weight of the polymer generally increases viscosity so that lower concentrations can be used.
  • An ideal solution is a 0.9% by weight solution of a polymer with an average molecular weight of 1.3 million.
  • FIGURE. 1 shows a block diagram of a sorting flow cytometer of the type described in the present invention.
  • FIGURE. 2 is a sectional view of a simple flow cell with the boundary layers shown to describe the development of laminar flow.
  • FIGURE 3 is an enlargement of detail '3' from FIG. 2, showing the pre-analysis section of the flowcell near the sheath inlet.
  • FIGURE 4 is an enlargement of detail '4' from FIG. 2, showing the flowcell exit with a droplet forming.
  • FIGURE 5 is a detail from FIG. 4 and shows a control volume for the droplet.
  • sheath and sample fluids are introduced into a flowcell in a pre-analysis section.
  • the sheath fluid forms a fully developed laminar flow profile within a short flow length (the entry length), and the sample fluid is injected into the center of this flow profile.
  • the sample fluid, containing a single file sequence of particles to be analyzed is kept centered in the flow channel by the laminar sheath flow, and is analyzed as it passes through an "interrogation" station (sensing zone) such as a laser beam traversing the flowcell, combined with one or more optical detectors.
  • the laser beam strikes the sample particles one by one as they pass through the interrogation station at a constant velocity.
  • Light scattered and emitted by each particle is detected by a series of optical detectors whose outputs are data that describe the optical characteristics of the analyzed particle. Because the sample particles are all centered, each particle shows a similar optical interaction with the laser beam. In the case of elongate multicellular organisms the centering process also aligns the long axis of the organism with the direction of flow. If the particles move from side to side as they pass through the laser beam, the detector data would be spurious due to fluctuations introduced by such random movement.
  • the flow passes into the analysis chamber or region of the flowcell, where the particles are measured and analyzed.
  • the rate at which the particles pass through the flowcell depends on the velocity of the fluid flow, which in turn depends on the flow rate.
  • flow rate cannot always be increased to increase the rate of particle analysis because above a certain velocity, the flow in the analysis chamber becomes unstable, laminar flow is lost and accurate measurements can no longer be made.
  • the present inventors have shown that increasing the viscosity of the sheath fluid increases the velocity at which the transition to unsteady flow occurs.
  • FIG. 2 shows a diagrammatic representation of a flowcell similar to one described by Shapiro (Shapiro Howard M. "Practical Flow Cytometry _ _
  • Sheath fluid enters through a sheath inlet tube 1 and enters the pre-analysis section of the cell through an orifice 11.
  • Sample fluid enters through a sample injector tube 2 and is injected into the center of the sheath flow through a second orifice 6.
  • the sheath fluid develops boundary layers 12 extending from the inside chamber wall and the outside wall of the sample injector tube 2.
  • the boundary layers converge at a point 5.
  • the flow converges and flows through an analysis section 8 of the cell, shown here as a quartz capillary.
  • the fluid exits the cell at a nozzle tip 9 and may form into a droplet 10 as shown or a solid stream in air (not illustrated) depending on the flow rates as discussed below.
  • FIG. 3 shows a close-up view of the boundary layers 17 to illustrate the development of laminar flow as discussed below.
  • the boundary layers are areas of viscous flow growing from the walls of the cavity, surrounding an area of inviscid flow 14 at the center.
  • the overall velocity profile is shown at an arbitrary point as 13.
  • Brodskey (Brodskey Robert S. "The Phenomena of Fluid Motions", 1995 Dover Publications Inc. Mineola NY., p. 120) gives an equation for a boundary layer growing on a flat plate as having the form:
  • boundary layers form simultaneously on both the inner and outer radii of an annular cavity, although the coefficient K will be different for the inner and outer layers, with the inner layer developing less quickly since the wall surface is smaller there.
  • the centerline velocity will be determined by the flow rate and geometry; generally for a cylindrical chamber:
  • FIG. 4 shows a small droplet forming on the exit nozzle 27, along with the velocity profile inside the nozzle.
  • FIG. 5 shows a control volume consisting of the droplet, with one entrance plane cutting across the tip of the outlet nozzle 27.
  • UCL is the centerline velocity and R is the radius of the tube. This will be the profile 29 as the fluid crosses the entrance plane of the droplet.
  • the momentum flux term can be found by integrating the differential momentum across the capillary:
  • the rate of flow required to sustain a "solid" stream of fluid in air is directly related to the diameter of the flow channel. Recall that such a solid stream is a prerequisite for the fluid switch sorting arrangement.
  • a flow rate of approximately 2.5 mL/min is needed to ensure a solid stream.
  • the required flow rate goes up eight fold to approximately 20 mL/min.
  • the flow rate increases to approximately 50 mL/min, a twenty-fold increase.
  • the maximum laminar flow rate is 14 mL/min, but the minimum rate for a solid exit stream is 20 mL/min.
  • PVP polyvinyl styrene
  • the maximum stable flow rate increases to over 40 mL/min while the minimum rate for a solid exit stream increases to 29 mL/min. That is, increased viscosity results in a higher laminar flow rate.
  • viscosity altering agents often increase the fluid surface tension, which results in an increase in the minimum flow rate necessary to sustain a solid flow stream. Because the viscosity effect is linearly related whereas the surface tension effect is related as the square root, a given viscosity-altering agent may actually render a given flowcell design useable where the same design would not operate at all with water.
  • Increased viscosity can be achieved with any number of additives dissolved in water, including polyvinyl pyrollidone (PVP), polyethylene glycol (PEG), polyvinyl alcohols, polyvinyl acetals, polyacrylic acids, polyacrylamides, plant gums (such as gum acacia and gum traganth), cellulose ethers (carboxymethyl cellulose), celluloses, hemicelluloses, dextrans, inulins, sucrose and other carbohydrates (monosaccharides, oligosaccharides and polysaccharides).
  • Non-aqueous fluids glycerol, propylene glycol, etc.
  • biological objects require a medium that is at least partially aqueous. For analysis of non-biological objects the fluids can be completely non-aqueous.
  • This invention is an improvement over current flow cytometry methods because it allows the flow cell channel to be enlarged without impairing other functions of the instrument.
  • use of a larger channel requires a decrease in the velocity at which the samples pass through the flowcell to ensure laminar flow, thereby limiting speed.
  • a larger channel also requires that the pre- analysis chamber or region be elongated to allow a sufficient distance for the sheath fluid to develop a steady laminar flow.
  • the current invention allows the use of a larger flow channel without any increase in the length of the pre-analysis chamber or decrease in fluid velocity.
  • the high-viscosity sheath reagent can be used to increase the analysis rate in a standard flow cytometer. Instead of running particles through a larger flow channel at the same velocity, particles can be run through the same flow channel at a higher velocity.
  • This invention is especially useful for systems which require that the stream exit into air as a solid stream and not as droplets. If the flow rate is too slow, the stream will form droplets and dribble from the exit nozzle. However, when the flow rate is increased to ensure formation of a solid stream, laminar flow in the flowcell may be lost unless the entry length is increased. As explained above, this entire problem is greatly exacerbated when the flow channel diameter is increased to accommodate elongated multicellular organisms. The use of high- viscosity sheath allows these systems to be run at a sufficiently high flow rate that the fluid exits the nozzle as a solid stream rather than as drops without impairing laminar flow.
  • sheath fluid One further advantage of the high-viscosity sheath fluid is that large particles often settle out of the sample fluid being analyzed before it reaches the flowcell. Increased viscosity of the sample fluid slows the rate at which the particles settle, making mixing of the samples easier and preventing settling in the sample lines.
  • the sheath and sample fluid must have the same refractive index or the sample fluid will scatter light even when no particle is present. This means that modification of sheath viscosity will normally require a similar modification of the sample fluid so that the indices of refraction match.
  • sucrose, glycerin and other low molecular weight compounds can be employed for viscosity modification, such materials will often have a significant osmotic effect at concentrations sufficient to significantly alter the viscosity.
  • excess osmoticum can distort the samples and even lead to a loss of viability. Therefore, it is preferred to use agents with a higher molecular weight, such as PEG polymers, PVP polymers or carbohydrate polymers. With such agents a significant increase in viscosity can be achieved with only a negligible increase in osmotic strength.
  • a potential drawback to the viscosity-increasing agents is that they generally increase the surface tension of the fluid. This requires a higher flow rate to ensure formation of a solid stream in air.
  • the surface tension effect is related to the square root of the surface tension increase while the velocity change in achieving laminar flow is linearly related to the increase in viscosity, with many agents the improvement due to viscosity increase more than outweighs the problems caused by an increase in surface tension.
  • a viscosity-increasing agent one should select agents that cause the largest increase in viscosity on a mole per mole basis while causing the smallest increase in surface tension on a molar basis.
  • a preferred sheath and sample fluid contain about 0.9% by weight PVP having a molecular weight of about 1.3 million.
  • PVP having a molecular weight of about 1.3 million.
  • testing of potential new drug compounds is a preferred use of the current invention. Therefore, long- term viability of the analyzed organisms is key.
  • the present inventors have tested the viability of Drosophila melanogaster larvae in both 5% PVP (40,000 MW) and 0.9% PVP (1.3 million MW) as well as a variety of concentrations and molecular weights between these figures and have found little, if any toxicity. This is hardly surprising since PVP use is allowed in a large number of food and medical products ranging from beer to hair preparations to eye drops.
  • PVP has been even used as a substitute for human plasma.
  • the overall viability exceeded 95% even after aerating the embryos for 8 hours in PVP with an antifoaming agent.
  • viability in PVP still exceeded 85%

Landscapes

  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A flow cytometer for the analysis of large particles or small multicellular organisms may experience unstable flow because of the large diameter of the flow chamber. The use of a sheath fluid or a sheath and sample with addition of a viscosity-increasing agent to give a viscosity higher than that of water ensures that flow in the pre-analysis section will be fully developed laminar flow, and that the flow in the analysis section will be laminar. This allows accurate analysis and sorting of large particles or analysis and sorting of smaller particles at an increased rate of speed. Water-soluble polymers are preferred because they increase fluid velocity with negligible osmotic effects. A 0.9 weight % solution of polyvinyl pyrollidone with an average molecular weight of 1.3 million is particularly effective. Use of viscosity-increasing agents that cause minimal increases in surface tension of the fluid is also preferred.

Description

HIGH VISCOSITY SHEATH REAGENT FOR FLOW CYTOMETRY
BACKGROUND OF THE INVENTION
The present application claims the priority and benefit of United States Provisional Patent Application 60/173,572 filed December 29, 1999.
1. Field of the Invention
This invention pertains to a technology for counting and analysis of particles, generally called flow cytometry. Specifically, the invention deals with improvements which allow flow cytometry devices to: 1) handle large particles, including small elongate multicellular organisms, which are considerably larger than the particles on which flow cytometry machines are usually used, and/or 2) operate at significantly increased speeds.
2. Description of Related Art
Flow cytometry instruments optically analyze particles suspended in a fluid stream as the particles pass through a focussed light beam. The instruments use hydrodynamic focusing to center particles in the fluid stream. To ensure accurate and stable centering, the fluid flow must be fully laminar, with no oscillations or turbulence. Needless to say, any imperfections in the hydrodynamic focusing degrade the performance of the instrument. Imperfect hydrodynamic focusing results in flow instabilities, and optical measurements are predicated upon the analyzed particle passing at a constant velocity through the center of the optical beam. In the face of instabilities and imperfect focussing these assumptions are not met and the resulting optical data are erroneous.
In a typical flow cytometer, a sheath stream and sample fluid stream (containing suspended particles to be analyzed) are introduced into the flowcell in a pre-analysis section (chamber) of the flowcell. The sheath stream is injected into the flowcell and allowed to flow for a sufficient distance to form a fully developed laminar flow profile. The sample stream is injected into the center of this flow profile. The sample fluid is thus kept centered in the flow channel of the flowcell by the laminar sheath flow that includes a velocity differential between the sheath and the sample streams. The centered sample particles are analyzed as they pass through an "interrogation" station where a beam such as a laser beam traverses the flowcell and strikes the suspended particles one by one. Light emitted or scattered by the particles is received by one or more optical detectors that output optical data in response to the incident light.
If, for some reason, the sheath flow has not fully developed into a laminar flow, random oscillations may develop in the fluid, and in general, once any such oscillations have started they cannot be damped out. These instabilities destroy the measurement precision of the instrument. Previous inventors have had the objective of improving the flow characteristics in flow cytometers. Edens et al, US Patent No. 5,808,737, discloses several methods of modifying the geometry of a pre-analysis chamber to improve measurement accuracy and decrease sample line length. North, Jr., US Patent No. 4,790,653, discloses a pre-analysis chamber having a diverging taper to help maintain laminar sheath flow. There has been an emphasis on adjusting the geometry of the flow chamber and associated components to ensure laminar flow.
The problems due to defects in laminar flow are exacerbated at especially high flow rates and by large particles. High flow rates increase turbulence. To accommodate large particles the diameter of the flow channel must be enlarged. To some extent laminar flow is stabilized by interactions between the flowing fluid and the channel walls. As the channel is enlarged the distance between the walls and portions of the fluid stream is increased, thereby favoring instabilities.
Several prior art inventions have also been designed to analyze and sort large particles. Hansen et al, PCT/US99/19035, filed 20 August 1999 and incorporated herein by reference, describes a method of sorting large particles and small multicellular organisms with flow cytometry principles by means of a fluid jet sorting mechanism. The flowcell and optics of this device are essentially similar to those of a typical flow cytometer. However, the diameter of the flow channel is increased to accommodate multicellular organisms such as nematodes and embryos of zebra fish and fruit flies. The typical laminar flow process not only centers the samples in the flow stream, it also orients the elongate organisms so that their long axis is parallel to the direction of flow. After the organisms pass through the laser beam and have their optical characteristics analyzed thereby, the fluid stream passes through a nozzle and becomes a solid sample stream in air (i.e., a continuous "solid" stream as opposed to a series of droplets).
The fluid stream is aimed into the well of a microtiter plate or other suitable receptacle. The entire fluid stream would be deposited in the well were it not for the "fluid switch". The fluid switch consists of a separate stream of focussed fluid which strikes the stream in air just below the flow cell. The separate stream diverts the sample stream in air so that it goes to waste and does not enter the microtiter well. Because this intersection occurs below the flowcell, any shock waves or instabilities caused by the intersection are not transmitted upstream into the analysis region where they would spoil the analysis.
The "fluid switch" diverting fluid stream (control stream) is controlled by a high-speed fluidic valve. When electronic analysis of the particles passing through the laser beam indicates that a desirable organism is present, the high-speed valve is closed at the correct instant to cause a section of stream in air containing the organism to pass unimpeded into the microtiter well. Then, the high-speed valve is reopened once again to divert the sample stream in air and prevent additional fluid or organisms from entering the microtiter well. The microtiter tray is moved mechanically to bring another well into position to receive the stream in air, and the entire process is repeated to deposit a single desired organism in the well. In this way each of the wells of the microtiter tray receive a single selected organism.
FIG. 1 represents a simplified block diagram of such an instrument. A source of suspended multicellular sample organisms 20 flow into the flowcell 24 which is represented by a dotted line. Sheath fluid from a container 22 enters the flowcell 24 and laminar flow develops as discussed below. At a sensing zone (analysis region) 26 a laser beam (not shown) traverses the flow cell 24 and illuminates the organisms. Emitted and scattered light are received by optical detectors 28. The signals are analyzed by a computer 30. The computer output controls a fluidic valve 34 which switches fluid (i.e., compressed gas) from a source 36. A control stream 38 emerging from the valve 34 is aimed onto a sample stream in air 40 that emerges from the lower end of the flowcell 26 forming a deflected stream 42 which goes to waste. In actual practice the deflected stream may be a mist of droplets. When the sample stream 40 is not deflected, the stream and the organism therein lands in the well 44 of a microtiter plate 46.
Instruments of this design are sold commercially by Union Biometrica, Inc. as the COPAS Technology Platform.
In addition, Becton Dickinson and Company manufacture instruments, including the FACStar Plus and the FACScaliber, which are available with special flowcells with larger than normal flow channels. These instruments are intended for use with samples suspended in water, buffer or biological saline.
SUMMARY OF THE INVENTION
The present inventors have found significant advantages to the use in flow-cytometry instruments of a sheath fluid with a viscosity significantly higher than that of water or biological saline. There are two primary situations where a viscous sheath is of especial advantage:
1) In the analysis and/or sorting of large particles, including small elongate multicellular organisms, without degradation of performance caused by instabilities in laminar flow;
2) In the analysis and/or sorting particles at a speed higher than could otherwise be achieved with a traditional flow cytometer;
The present inventors have found that increasing the viscosity of the sheath fluid dramatically decreases the flow length required to stabilize fully the flow.
This invention is critical for systems which require that the stream exit into air as a solid stream and not as droplets. If the flow rate is too slow, the stream will form droplets and drip out of the exit nozzle. The high-viscosity sheath allows these systems to be run at a flow rate sufficiently high that the fluid exits the nozzle as a solid stream rather than as a series of drops. An additional advantage of the high-viscosity sheath fluid is that large particles often settle out of the sample being analyzed before it reaches the flowcell. Increased viscosity of the sample fluid slows the rate at which the particles settle, making mixing of the samples easier and preventing settling in the sample lines. It should be kept in mind that if light scatter is used to detect and measure the particles, the sheath and sample fluid must have the same refractive index or the sample fluid will scatter light even when no particle is present. This means that modification of sheath viscosity will normally require a similar modification of the sample fluid.
The preferred embodiment of this invention consists of a short pre- analysis chamber, in which the sheath is delivered aligned with the axis of the flowcell (for example, through two opposed ports), an analysis chamber with a wide (1 mm) flow channel, and a nozzle through which the flow stream is discharged to air at the downstream end of the analysis section. In the preferred embodiment, a solid stream of fluid is diverted by a switchable fluid stream (e.g. gas), which is turned off to dispense a particle. Although a large number of different viscosity-increasing agents can be used in the present invention the preferred agent is polyvinyl pyrollidone (PVP). This material can be effectively used over a considerable range of solution concentrations and molecular weight compositions. For example, a 5% by weight solution of a polymer with a 40,000 average molecular weight is effective. Increasing the molecular weight of the polymer generally increases viscosity so that lower concentrations can be used. An ideal solution is a 0.9% by weight solution of a polymer with an average molecular weight of 1.3 million.
Description of the Figures
FIGURE. 1 shows a block diagram of a sorting flow cytometer of the type described in the present invention.
FIGURE. 2 is a sectional view of a simple flow cell with the boundary layers shown to describe the development of laminar flow.
FIGURE 3 is an enlargement of detail '3' from FIG. 2, showing the pre-analysis section of the flowcell near the sheath inlet. FIGURE 4 is an enlargement of detail '4' from FIG. 2, showing the flowcell exit with a droplet forming.
FIGURE 5 is a detail from FIG. 4 and shows a control volume for the droplet.
Detailed Description of the Invention
The following description is provided to enable any person skilled in the art to make and use the invention and sets forth the best modes contemplated by the inventors of carrying out their invention. Various modifications, however, will remain readily apparent to those skilled in the art, since the general principles of the present invention have been defined herein specifically to provide a method for increasing the size of particles analyzed and the overall rate of particle analysis in a hydro- dynamically focussed flow cytometer by increasing the viscosity of the instrument's sheath reagent.
In a flow cytometer, sheath and sample fluids are introduced into a flowcell in a pre-analysis section. The sheath fluid forms a fully developed laminar flow profile within a short flow length (the entry length), and the sample fluid is injected into the center of this flow profile. The sample fluid, containing a single file sequence of particles to be analyzed is kept centered in the flow channel by the laminar sheath flow, and is analyzed as it passes through an "interrogation" station (sensing zone) such as a laser beam traversing the flowcell, combined with one or more optical detectors.
The laser beam strikes the sample particles one by one as they pass through the interrogation station at a constant velocity. Light scattered and emitted by each particle is detected by a series of optical detectors whose outputs are data that describe the optical characteristics of the analyzed particle. Because the sample particles are all centered, each particle shows a similar optical interaction with the laser beam. In the case of elongate multicellular organisms the centering process also aligns the long axis of the organism with the direction of flow. If the particles move from side to side as they pass through the laser beam, the detector data would be spurious due to fluctuations introduced by such random movement.
If, for some reason, the sheath flow has not fully developed into a laminar flow before the sample particles reach the laser beam, random oscillations may develop in the fluid, and in general, once any such oscillations have begun they will not spontaneously be damped out. These instabilities destroy the measurement precision of the instrument. As discussed below, the pre-analysis region of the flowcell can be increased to allow more length for a stable flow to develop. However, other factors militate against this approach. The present inventors have found that increasing the viscosity of the sheath fluid dramatically decreases the length required to stabilize the flow.
From the pre-analysis chamber or region, the flow passes into the analysis chamber or region of the flowcell, where the particles are measured and analyzed. The rate at which the particles pass through the flowcell depends on the velocity of the fluid flow, which in turn depends on the flow rate. Unfortunately, flow rate cannot always be increased to increase the rate of particle analysis because above a certain velocity, the flow in the analysis chamber becomes unstable, laminar flow is lost and accurate measurements can no longer be made. The present inventors have shown that increasing the viscosity of the sheath fluid increases the velocity at which the transition to unsteady flow occurs.
FIG. 2 shows a diagrammatic representation of a flowcell similar to one described by Shapiro (Shapiro Howard M. "Practical Flow Cytometry _ _
3rd ed.", 1995 Wiley-Liss, Inc. New York, p. 120). Sheath fluid enters through a sheath inlet tube 1 and enters the pre-analysis section of the cell through an orifice 11. Sample fluid enters through a sample injector tube 2 and is injected into the center of the sheath flow through a second orifice 6. The sheath fluid develops boundary layers 12 extending from the inside chamber wall and the outside wall of the sample injector tube 2. The boundary layers converge at a point 5. After the sample injection, the flow converges and flows through an analysis section 8 of the cell, shown here as a quartz capillary. The fluid exits the cell at a nozzle tip 9 and may form into a droplet 10 as shown or a solid stream in air (not illustrated) depending on the flow rates as discussed below.
FIG. 3 shows a close-up view of the boundary layers 17 to illustrate the development of laminar flow as discussed below. The boundary layers are areas of viscous flow growing from the walls of the cavity, surrounding an area of inviscid flow 14 at the center. The overall velocity profile is shown at an arbitrary point as 13. Brodskey (Brodskey Robert S. "The Phenomena of Fluid Motions", 1995 Dover Publications Inc. Mineola NY., p. 120) gives an equation for a boundary layer growing on a flat plate as having the form:
Figure imgf000011_0001
In the flowcell of FIG. 2, boundary layers form simultaneously on both the inner and outer radii of an annular cavity, although the coefficient K will be different for the inner and outer layers, with the inner layer developing less quickly since the wall surface is smaller there. The thickness of the inner boundary layer at some arbitrary value of x is shown as 16, and the thickness of the outer layer as 15. At some point downstream, the boundary layers will converge. This point (18 here) marks the entrance length, the point at which the laminar flow profile in the annulus is fully developed. The thickness of either boundary layer at this point will be determined solely by the values of K for the two layers, represented by the subscripts i and o, and by the gap a. Denoting the entrance length as x = Le,:
'-'£ (2)
Figure imgf000012_0001
Thus either boundary layer thickness is fixed at this point. Using the centerline velocity UCL in place of the free stream velocity U∞, eq. (1) becomes:
Figure imgf000012_0002
The centerline velocity will be determined by the flow rate and geometry; generally for a cylindrical chamber:
Q πUCLR (4)
Substituting into equation (3) gives
Figure imgf000013_0001
The condition for stable, laminar flow in the pre-analysis section of the cell is that the point 5, 18 where the boundary layers converge must be upstream of the point 6 where the sample is injected. From this condition, equation (5) dictates that the length of the flowcell must increase in direct proportion to the flowrate through it.
FIG. 4 shows a small droplet forming on the exit nozzle 27, along with the velocity profile inside the nozzle. FIG. 5 shows a control volume consisting of the droplet, with one entrance plane cutting across the tip of the outlet nozzle 27.
Inside the exit nozzle 27, the flow will exhibit the traditional parabolic laminar flow profile 26; from Brodskey (p.90) the steady-state is:
Figure imgf000013_0002
UCL = 2U (6) u Q
where UCL is the centerline velocity and R is the radius of the tube. This will be the profile 29 as the fluid crosses the entrance plane of the droplet.
The sum of forces obeys Newton's second law; taking force in the +x direction to be positive,
Figure imgf000013_0003
where Wis the weight of the droplet, Fsr is the force 28 exerted across the entrance plane by the surface tension , and J is the momentum flux into the droplet across the entrance plane.
By taking the moment when the droplet begins to form, the weight will be neghgible. The momentum flux term can be found by integrating the differential momentum across the capillary:
Figure imgf000014_0001
dj(r) = U(r)dnS = pU2 (r)dA
Putting the equation in cylindrical coordinates,
dj(r)= pU2{r)rdrdθ (8b)
and substituting the velocity profile from equation (6) gives:
Figure imgf000014_0002
Integrating across the nozzle and substituting the volume flow rate Q from equation (6) gives:
Figure imgf000014_0003
4p
J = πpU2R2 = r
3πR2 Substituting into equation (7), and taking the definition of the surface tension F = PY where F is the force exerted, P is the length of the cut surface, and Y is the surface tension:
3πR2
Figure imgf000015_0001
Thus, the rate of flow required to sustain a "solid" stream of fluid in air is directly related to the diameter of the flow channel. Recall that such a solid stream is a prerequisite for the fluid switch sorting arrangement. When the exit nozzle from the flowcell is only 0.25 mm in diameter, a flow rate of approximately 2.5 mL/min is needed to ensure a solid stream. When the nozzle is increased four fold to 1 mm, the required flow rate goes up eight fold to approximately 20 mL/min. When the nozzle is increased to 2 mm (an eight-fold increase), the flow rate increases to approximately 50 mL/min, a twenty-fold increase.
At a fixed nozzle size, alteration of viscosity has no effect on the minimum flow rate. However, many viscosity-altering agents also change the surface tension of the liquid. The minimum flow rate varies as the 1.5 power of the nozzle diameter and as the 0.5 power of the fluid's surface tension. At a given nozzle size, the maximum flow rate for stable flow inside the flowcell increases linearly with increasing viscosity. At the same time the minimum flow rate for a solid exit stream varies with the square root of the surface tension of the fluid. Thus, if a given agent doubles the viscosity and doubles the surface tension, the maximum stable flow rate will double while the minimum solid flow rate will increase by 41%. For instance, 5% (by weight) PVP (40,000 MW) gives an increase of 180% in the viscosity and apparent increase of 125% in the surface tension. This nearly triples the flow rate at which stable laminar flow is possible but only increases the minimum solid flow rate by about 50%.
In the preferred design for a 1 mm flow channel flow cell (Fig. 1) the maximum laminar flow rate is 14 mL/min, but the minimum rate for a solid exit stream is 20 mL/min. By adding PVP (either 5% by weight of 40,000 MN or 0.9% of 1.3 million MW), the maximum stable flow rate increases to over 40 mL/min while the minimum rate for a solid exit stream increases to 29 mL/min. That is, increased viscosity results in a higher laminar flow rate. However, viscosity altering agents often increase the fluid surface tension, which results in an increase in the minimum flow rate necessary to sustain a solid flow stream. Because the viscosity effect is linearly related whereas the surface tension effect is related as the square root, a given viscosity-altering agent may actually render a given flowcell design useable where the same design would not operate at all with water.
With too short an entrance length (Le), or too high a flow rate, the flow will not be fully stabilized when it reaches the laser beam. If the flow is unstable, the cytometer performs poorly because the optical measurements are inexact. If one increases V in order to get, in the case of a solid stream in air system, the nozzle to emit a solid fluid stream in air, one has to increase Le proportionately to ensure that flow at the laser beam is laminar. Such an approach results in a rapid increase in the entry length of the flowcell. For all practical purposes this results in an instrument with an excessively long flowcell which may be difficult to construct or accommodate.
The calculations show the usefulness of increasing the sheath viscosity even when increasing the diameter of the flowcell is not desired. Using a crude approximation one sees that increasing v by a factor of 2, while leaving D and Le the same (i.e., leaving the geometry of the flowcell unchanged), one can increase V (approximately by a factor of 2 as well). So, for the same sample dilution (which has been set to prevent clogging and coincident particles), one can run twice as many particles per second without sacrificing laminar flow. On the contrary if one tries to increase V without increasing the viscosity or altering the flowcell geometry, the flow becomes unstable.
Increased viscosity can be achieved with any number of additives dissolved in water, including polyvinyl pyrollidone (PVP), polyethylene glycol (PEG), polyvinyl alcohols, polyvinyl acetals, polyacrylic acids, polyacrylamides, plant gums (such as gum acacia and gum traganth), cellulose ethers (carboxymethyl cellulose), celluloses, hemicelluloses, dextrans, inulins, sucrose and other carbohydrates (monosaccharides, oligosaccharides and polysaccharides). Non-aqueous fluids (glycerol, propylene glycol, etc.) can also be used to increase viscosity as long as they are water miscible. Generally, biological objects require a medium that is at least partially aqueous. For analysis of non-biological objects the fluids can be completely non-aqueous.
This invention is an improvement over current flow cytometry methods because it allows the flow cell channel to be enlarged without impairing other functions of the instrument. With water or biological saline as the sheath, use of a larger channel requires a decrease in the velocity at which the samples pass through the flowcell to ensure laminar flow, thereby limiting speed. A larger channel also requires that the pre- analysis chamber or region be elongated to allow a sufficient distance for the sheath fluid to develop a steady laminar flow. The current invention allows the use of a larger flow channel without any increase in the length of the pre-analysis chamber or decrease in fluid velocity.
Furthermore, the high-viscosity sheath reagent can be used to increase the analysis rate in a standard flow cytometer. Instead of running particles through a larger flow channel at the same velocity, particles can be run through the same flow channel at a higher velocity.
This invention is especially useful for systems which require that the stream exit into air as a solid stream and not as droplets. If the flow rate is too slow, the stream will form droplets and dribble from the exit nozzle. However, when the flow rate is increased to ensure formation of a solid stream, laminar flow in the flowcell may be lost unless the entry length is increased. As explained above, this entire problem is greatly exacerbated when the flow channel diameter is increased to accommodate elongated multicellular organisms. The use of high- viscosity sheath allows these systems to be run at a sufficiently high flow rate that the fluid exits the nozzle as a solid stream rather than as drops without impairing laminar flow.
One further advantage of the high-viscosity sheath fluid is that large particles often settle out of the sample fluid being analyzed before it reaches the flowcell. Increased viscosity of the sample fluid slows the rate at which the particles settle, making mixing of the samples easier and preventing settling in the sample lines. However, it should be kept in mind that if light scatter is used to detect and measure the particles, the sheath and sample fluid must have the same refractive index or the sample fluid will scatter light even when no particle is present. This means that modification of sheath viscosity will normally require a similar modification of the sample fluid so that the indices of refraction match. Because the sample fluid often requires the same or similar modification as the sheath fluid some attention must be paid to the osmotic effects of the viscosity-modifying agent. Although sucrose, glycerin and other low molecular weight compounds can be employed for viscosity modification, such materials will often have a significant osmotic effect at concentrations sufficient to significantly alter the viscosity. In the case of biological samples excess osmoticum can distort the samples and even lead to a loss of viability. Therefore, it is preferred to use agents with a higher molecular weight, such as PEG polymers, PVP polymers or carbohydrate polymers. With such agents a significant increase in viscosity can be achieved with only a negligible increase in osmotic strength.
A potential drawback to the viscosity-increasing agents is that they generally increase the surface tension of the fluid. This requires a higher flow rate to ensure formation of a solid stream in air. However, because the surface tension effect is related to the square root of the surface tension increase while the velocity change in achieving laminar flow is linearly related to the increase in viscosity, with many agents the improvement due to viscosity increase more than outweighs the problems caused by an increase in surface tension. Nevertheless, when selecting a viscosity-increasing agent, one should select agents that cause the largest increase in viscosity on a mole per mole basis while causing the smallest increase in surface tension on a molar basis. Generally high molecular weight polymers will cause the greatest increase of viscosity on a molar basis. These same polymers are also the most likely to be nontoxic to organisms because such large polymers are unable to penetrate cell membranes. Other factors being equal, agents with the smallest molar effect on surface tension should be selected. Hydrophilic polymers such as PVP are known to show some surfactant activity and cause a smaller increase in surface tension. However, because of the mathematical relationships explained above, especially favorable viscosity and toxicity properties can often outweigh unfavorable surface tension properties.
Currently a preferred sheath and sample fluid contain about 0.9% by weight PVP having a molecular weight of about 1.3 million. When used to analyze and/or sort multicellular animals, testing of potential new drug compounds is a preferred use of the current invention. Therefore, long- term viability of the analyzed organisms is key. The present inventors have tested the viability of Drosophila melanogaster larvae in both 5% PVP (40,000 MW) and 0.9% PVP (1.3 million MW) as well as a variety of concentrations and molecular weights between these figures and have found little, if any toxicity. This is hardly surprising since PVP use is allowed in a large number of food and medical products ranging from beer to hair preparations to eye drops. PVP has been even used as a substitute for human plasma. The overall viability exceeded 95% even after aerating the embryos for 8 hours in PVP with an antifoaming agent. When the embryos are "dechorionated" by treatment in bleach, viability in PVP still exceeded 85%
The following claims are thus to be understood to include what is specifically illustrated and described above, what is conceptually equivalent, and what can be obviously substituted. Those skilled in the art will appreciate that various adaptations and modifications of the just- described preferred embodiment can be configured without departing from the scope of the invention. The illustrated embodiment has been set forth only for the purposes of example and that should not be taken as limiting the invention. Therefore, it is to be understood that, within the scope of the appended claims, the invention may be practiced other than as specifically described herein.

Claims

CLAIMSWhat Is Claimed Is:
1. A method for maintaining laminar flow in a flow cytometer flow chamber comprising adding a viscosity-increasing agent to a fluid flowing through said flow chamber.
2. The method of Claim 1 , wherein the viscosity-increasing agent is a water-soluble organic polymer with an average molecular weight between 10,000 and 10,000,000.
3. The method of Claim 2, wherein the water-soluble organic polymer has an average molecular weight of at least 1 ,000,000.
4. The method of Claim 2, wherein the water-soluble organic polymer is selected from the group consisting of polyvinyl pyrollidone, polyethylene glycols, polyvinyl alcohols, polyvinyl acetals, polyacrylic acids, polyacrylamides, plant gums, cellulose ethers, celluloses, hemicelluloses, dextrans, inulins, oligosaccharides and polysaccharides.
5. The method of Claim 1 , wherein the viscosity-increasing agent is selected to minimize increases in surface tension of the fluid.
6. The method of Claim 1 , wherein the viscosity-increasing agent is selected to minimize increases in osmotic strength of the fluid.
7. The method of Claim 1 , wherein the fluid is one of sheath fluid, or both sheath fluid and sample fluid.
8. A sorting flow cytometer of the type where elongate multicellular organisms are passed through a flow cell and the organisms are subsequently sorted from a solid fluid stream in air by a controlled diverting fluid stream characterized in that a length of the flow cell is decreased and flow rate of a fluid through the flowcell is increased by adding a viscosity- increasing agent to the fluid flowing through the flowcell.
9. The sorting flow cytometer of Claim 8, wherein the viscosity-increasing agent is a water-soluble organic polymer with an average molecular weight between 10,000 and 10,000,000.
10. The sorting flow cytometer of Claim 9, wherein the water- soluble organic polymer has an average molecular weight of at least
1 ,000,000. _ .
11. The sorting flow cytometer of Claim 9, wherein the water- soluble organic polymer is selected from the group consisting of polyvinyl pyrollidone, polyethylene glycols, polyvinyl alcohols, polyvinyl acetals, polyacrylic acids, polyacrylamides, plant gums, cellulose ethers, celluloses, hemicelluloses, dextrans, inulins, oligosaccharides and polysaccharides.
12. The sorting flow cytometer of Claim 8, wherein the viscosity-increasing agent is selected to minimize increases in surface tension of the fluid.
13. The sorting flow cytometer of Claim 8, wherein the viscosity-increasing agent is selected to minimize increases in osmotic strength of the fluid.
14. The sorting flow cytometer of Claim 8, wherein the fluid is one of sheath fluid, or both sheath fluid and sample fluid.
PCT/US2000/035543 1999-12-29 2000-12-29 High viscosity sheath reagent for flow cytometry Ceased WO2001048455A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU26063/01A AU2606301A (en) 1999-12-29 2000-12-29 High viscosity sheath reagent for flow cytometry
JP2001548919A JP2004500562A (en) 1999-12-29 2000-12-29 High viscosity sheath reagent for flow cytometry
CA002396015A CA2396015A1 (en) 1999-12-29 2000-12-29 High viscosity sheath reagent for flow cytometry
EP00989570A EP1242804A2 (en) 1999-12-29 2000-12-29 High viscosity sheath reagent for flow cytometry
US10/203,841 US20040070757A1 (en) 2000-12-29 2000-12-29 High viscosity sheath reagent for flow cytometry

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17357299P 1999-12-29 1999-12-29
US60/173,572 1999-12-29

Publications (2)

Publication Number Publication Date
WO2001048455A2 true WO2001048455A2 (en) 2001-07-05
WO2001048455A3 WO2001048455A3 (en) 2002-05-10

Family

ID=22632632

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/035543 Ceased WO2001048455A2 (en) 1999-12-29 2000-12-29 High viscosity sheath reagent for flow cytometry

Country Status (5)

Country Link
EP (1) EP1242804A2 (en)
JP (1) JP2004500562A (en)
AU (1) AU2606301A (en)
CA (1) CA2396015A1 (en)
WO (1) WO2001048455A2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7116407B2 (en) 1998-12-15 2006-10-03 Union Biometrica, Inc. System for axial pattern analysis of multicellular organisms
US7468789B2 (en) * 2004-02-05 2008-12-23 Advanced Analytical Technologies, Inc. Flow cytometer for rapid bacteria detection
WO2014146030A1 (en) * 2013-03-15 2014-09-18 Iris International, Inc. Flowcell systems and methods for particle analysis in blood samples
WO2014145983A1 (en) * 2013-03-15 2014-09-18 Iris International, Inc. Sheath fluid systems and methods for particle analysis in blood samples
WO2014146062A3 (en) * 2013-03-15 2014-12-18 Iris International, Inc. Flowcell, sheath fluid, and autofocus systems and methods for particle analysis in urine samples
WO2017167361A1 (en) * 2016-03-30 2017-10-05 Siemens Healthcare Gmbh Aligning a non-spherical biological entity in a sample flow using ambient viscoelastic fluid flows
US10060836B2 (en) 2011-03-09 2018-08-28 Pixcell Medical Technologies Ltd Disposable cartridge for preparing a sample fluid containing cells for analysis
EP4124846A1 (en) * 2021-07-29 2023-02-01 Technische Universität München Detection of cell aggregates using quantitative phase-contrast microscopy
WO2023006372A1 (en) * 2021-07-29 2023-02-02 Technische Universität München Detection of molecular biological objects, cellular biological objects and cell aggregates using quantitative phase-contrast microscopy

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4606261B2 (en) * 2005-07-13 2011-01-05 三井造船株式会社 Particle measurement method
US7867778B2 (en) * 2007-02-23 2011-01-11 Visiongate, Inc. Fluid focusing for positional control of a specimen for 3-D imaging
US8642288B2 (en) * 2007-06-07 2014-02-04 Technion Research & Development Foundation Ltd. Methods for viscoelastic focusing of particles
JP2009115672A (en) * 2007-11-08 2009-05-28 Sony Corp Optical measurement method and fractionation method of microparticles, and flow path, optical measurement device and flow cytometer used in the optical measurement method and fractionation method
JP4556996B2 (en) 2007-12-13 2010-10-06 ソニー株式会社 Optical detection method
JP6716057B2 (en) * 2016-04-08 2020-07-01 富山県 Method and device for separating cells
CN111132765B (en) * 2017-09-19 2022-05-13 高保真生物技术有限公司 Particle sorting in microfluidic systems

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0626455B1 (en) * 1993-05-28 1998-07-15 Enea Ente Per Le Nuove Tecnologie, L'energia E L'ambiente Method of analysis, separation and micro-encapsulation of cell elements
JPH09126989A (en) * 1995-11-07 1997-05-16 Hitachi Ltd Flow-type particle image analyzer
US6130309A (en) * 1996-09-20 2000-10-10 Tyndale Plains-Hunter, Ltd. Hydrophilic polyether polyurethanes containing carboxylic acid

Cited By (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7116407B2 (en) 1998-12-15 2006-10-03 Union Biometrica, Inc. System for axial pattern analysis of multicellular organisms
US7468789B2 (en) * 2004-02-05 2008-12-23 Advanced Analytical Technologies, Inc. Flow cytometer for rapid bacteria detection
US10983033B2 (en) 2011-03-09 2021-04-20 Pixcell Medical Technologies Ltd. Disposable cartridge for preparing a sample fluid containing cells for analysis
US10060836B2 (en) 2011-03-09 2018-08-28 Pixcell Medical Technologies Ltd Disposable cartridge for preparing a sample fluid containing cells for analysis
CN105143850B (en) * 2013-03-15 2018-08-21 艾瑞思国际股份有限公司 Autofocusing systems and methods for particle analysis in blood samples
US11543340B2 (en) 2013-03-15 2023-01-03 Iris International, Inc. Autofocus systems and methods for particle analysis in blood samples
WO2014146062A3 (en) * 2013-03-15 2014-12-18 Iris International, Inc. Flowcell, sheath fluid, and autofocus systems and methods for particle analysis in urine samples
WO2014146063A3 (en) * 2013-03-15 2015-01-08 Iris International, Inc. Hematology systems and methods
KR20150129712A (en) * 2013-03-15 2015-11-20 아이리스 인터내셔널 인크. Flowcell systems and methods for particle analysis in blood samples
KR20150129709A (en) * 2013-03-15 2015-11-20 아이리스 인터내셔널 인크. Hematology systems and methods
KR20150129706A (en) * 2013-03-15 2015-11-20 아이리스 인터내셔널 인크. Sheath fluid systems and methods for particle analysis in blood samples
CN109142195A (en) * 2013-03-15 2019-01-04 艾瑞思国际股份有限公司 Autofocus system and method for the particle analysis in humoral sample
CN105143849A (en) * 2013-03-15 2015-12-09 艾瑞思国际股份有限公司 Dynamic range extension systems and methods for particle analysis in blood samples
CN105143850A (en) * 2013-03-15 2015-12-09 艾瑞思国际股份有限公司 Autofocusing systems and methods for particle analysis in blood samples
US9316635B2 (en) 2013-03-15 2016-04-19 Iris International, Inc. Sheath fluid systems and methods for particle analysis in blood samples
US9322752B2 (en) 2013-03-15 2016-04-26 Iris International, Inc. Flowcell systems and methods for particle analysis in blood samples
JP2016519758A (en) * 2013-03-15 2016-07-07 アイリス インターナショナル, インコーポレイテッド Flow cell system and method for analysis of particles in blood samples
JP2016519759A (en) * 2013-03-15 2016-07-07 アイリス インターナショナル, インコーポレイテッド Automatic focusing system and method for analysis of particles in blood samples
JP2016519760A (en) * 2013-03-15 2016-07-07 アイリス インターナショナル, インコーポレイテッド Flow cell, sheath fluid, and autofocus system and method for particle analysis in urine samples
JP2016520807A (en) * 2013-03-15 2016-07-14 アイリス インターナショナル, インコーポレイテッド Blood test system and method
JP2016520805A (en) * 2013-03-15 2016-07-14 アイリス インターナショナル, インコーポレイテッド Sheath fluid system and method for particle analysis in blood samples
US9470618B2 (en) 2013-03-15 2016-10-18 Iris International, Inc. Sheath fluid systems and methods for particle analysis in blood samples
CN105102959B (en) * 2013-03-15 2017-06-09 艾瑞思国际股份有限公司 For the flow cell system and method for the grading analysis in blood sample
US9702806B2 (en) 2013-03-15 2017-07-11 Iris International, Inc. Hematology systems and methods
EP2972200B1 (en) * 2013-03-15 2024-08-14 Iris International, Inc. Hematology systems and methods
US9857361B2 (en) 2013-03-15 2018-01-02 Iris International, Inc. Flowcell, sheath fluid, and autofocus systems and methods for particle analysis in urine samples
US9909973B2 (en) 2013-03-15 2018-03-06 Iris International, Inc. Flowcell systems and methods for particle analysis in blood samples
WO2014145983A1 (en) * 2013-03-15 2014-09-18 Iris International, Inc. Sheath fluid systems and methods for particle analysis in blood samples
WO2014146051A1 (en) * 2013-03-15 2014-09-18 Iris International, Inc. Autofocus systems and methods for particle analysis in blood samples
US10060846B2 (en) 2013-03-15 2018-08-28 Iris International, Inc. Hematology systems and methods
WO2014146061A1 (en) * 2013-03-15 2014-09-18 Iris International, Inc. Dynamic range extension systems and methods for particle analysis in blood samples
EP2972215B1 (en) * 2013-03-15 2024-06-26 Iris International, Inc. Methods for particle analysis in body fluid
CN105122034A (en) * 2013-03-15 2015-12-02 艾瑞思国际股份有限公司 Flow cell, sheath fluid and autofocus system and method for particle analysis in urine samples
CN105143849B (en) * 2013-03-15 2019-01-11 艾瑞思国际股份有限公司 Automatic dynamic range expansion system and method for particle analysis in blood sample
CN105122034B (en) * 2013-03-15 2019-03-29 艾瑞思国际股份有限公司 Autofocus system and method for particle analysis in urine samples
EP3467472A1 (en) * 2013-03-15 2019-04-10 Iris International, Inc. Sheath fluid systems and methods for particle analysis in blood samples
EP3489656A1 (en) * 2013-03-15 2019-05-29 Iris International, Inc. Flowcell systems and methods for particle analysis in biological fluid samples
US10345217B2 (en) 2013-03-15 2019-07-09 Iris International, Inc. Flowcell systems and methods for particle analysis in blood samples
US10429292B2 (en) 2013-03-15 2019-10-01 Iris International, Inc. Dynamic range extension systems and methods for particle analysis in blood samples
US10451612B2 (en) 2013-03-15 2019-10-22 Iris International, Inc. Sheath fluid systems and methods for particle analysis in blood samples
KR102044593B1 (en) 2013-03-15 2019-11-13 아이리스 인터내셔널 인크. Hematology systems and methods
KR102053487B1 (en) 2013-03-15 2019-12-06 아이리스 인터내셔널 인크. Sheath fluid systems and methods for particle analysis in blood samples
KR102055474B1 (en) 2013-03-15 2019-12-12 아이리스 인터내셔널 인크. Flowcell systems and methods for particle analysis in blood samples
CN113484200B (en) * 2013-03-15 2024-04-26 艾瑞思国际股份有限公司 Hematology systems and methods
US10705008B2 (en) 2013-03-15 2020-07-07 Iris International, Inc. Autofocus systems and methods for particle analysis in blood samples
US10794900B2 (en) 2013-03-15 2020-10-06 Iris International, Inc. Flowcell, sheath fluid, and autofocus systems and methods for particle analysis in urine samples
WO2014146030A1 (en) * 2013-03-15 2014-09-18 Iris International, Inc. Flowcell systems and methods for particle analysis in blood samples
EP3842785A1 (en) * 2013-03-15 2021-06-30 Iris International, Inc. Sheath fluid systems and methods for particle analysis in blood samples
CN113484200A (en) * 2013-03-15 2021-10-08 艾瑞思国际股份有限公司 Hematology system and method
US11525766B2 (en) 2013-03-15 2022-12-13 Iris International, Inc. Dynamic range extension systems and methods for particle analysis in blood samples
CN109100288A (en) * 2013-03-15 2018-12-28 艾瑞思国际股份有限公司 Sheath fluid system and method for the particle analysis in blood sample
EP2972210B1 (en) * 2013-03-15 2024-03-27 Iris International, Inc. Dynamic range extension systems and methods for particle analysis in blood samples
US10656070B2 (en) 2016-03-30 2020-05-19 Siemens Healthcare Gmbh Aligning a non-spherical biological entity in a sample flow using ambient viscoelastic fluid flows
CN108780031A (en) * 2016-03-30 2018-11-09 西门子保健有限责任公司 Use environment viscoelastic fluid stream is directed at the aspherical biological entities in sample flow
WO2017167361A1 (en) * 2016-03-30 2017-10-05 Siemens Healthcare Gmbh Aligning a non-spherical biological entity in a sample flow using ambient viscoelastic fluid flows
EP4124847A1 (en) * 2021-07-29 2023-02-01 Technische Universität München Detection of cell aggregates using quantitative phase-contrast microscopy
WO2023006372A1 (en) * 2021-07-29 2023-02-02 Technische Universität München Detection of molecular biological objects, cellular biological objects and cell aggregates using quantitative phase-contrast microscopy
WO2023006996A1 (en) * 2021-07-29 2023-02-02 Technische Universität München Detection of cell aggregates using quantitative phase-contrast microscopy
EP4124846A1 (en) * 2021-07-29 2023-02-01 Technische Universität München Detection of cell aggregates using quantitative phase-contrast microscopy

Also Published As

Publication number Publication date
WO2001048455A3 (en) 2002-05-10
JP2004500562A (en) 2004-01-08
EP1242804A2 (en) 2002-09-25
CA2396015A1 (en) 2001-07-05
AU2606301A (en) 2001-07-09

Similar Documents

Publication Publication Date Title
WO2001048455A2 (en) High viscosity sheath reagent for flow cytometry
US10648899B2 (en) Method for sorting cell particle in solution
EP0029662B1 (en) Automated method for cell volume determination
US6365106B1 (en) Sheath flow cell and blood analyzer using the same
Johnson et al. Modification of a laser‐based flow cytometer for high‐resolution DNA analysis of mammalian spermatozoa
KR100909862B1 (en) Improved flow cytometer nozzle and flow cytometer sampling method
US20040070757A1 (en) High viscosity sheath reagent for flow cytometry
US4110043A (en) Apparatus for counting and classifying particles
JP4965561B2 (en) Cytometer cell counting and sizing system
US3822095A (en) System for differentiating particles
EP1841537B1 (en) Methods and apparatus for sorting particles hydraulically
US4710021A (en) Particulate matter analyzing apparatus and method
US3819270A (en) Blood cell analyzer
RU2414694C2 (en) Optical device for analysing blood, analyser fitted with said device
JPH0726956B2 (en) Dissolving agent and its use
US20210033521A1 (en) Flow cytometer and method of analysis
US4343551A (en) Apparatus for counting and classifying particles
JP7315543B2 (en) Measurement cuvettes for counting and/or characterizing cells
Miyhake et al. Flow cytometric analysis by using micro-machined flow chamber
Eisert High resolution optics combined with high spatial reproducibility in flow
US7551278B2 (en) Fluid light guide system
Kraft Laser Fibers to Detect and Collect Fluorescent Beads
Lieberman Parameters controlling counting efficiency for optical liquid-borne particle counters
Eisert et al. Nozzle design for the generation of plane liquid surfaces
Amblard Fluid Mechanical Properties of Flow Cytometers and Assessment Cell-Cell Adhesion Forces

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 548919

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2396015

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000989570

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000989570

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10203841

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2000989570

Country of ref document: EP